Delivery Order SPE2DB20D3111-SPE2DB24FA7NU
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,092.97 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,500.96 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4559291100 - Ondansetron ODT 4 mg Tablets. This delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver 4,561,783,106 units of Ondansetron ODT 4 mg tablets. The $4,427.20 firm-fixed-price delivery order has an ultimate completion date of August 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,560,616,544 units of Ondansetron ODT 4 mg tablets in 30-count packages. The award has a ceiling value of $1,902.33 and an ultimate completion date of April 18, 2023. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,245.96 firm fixed-price delivery order is for 4,564,413,840 units of the medication Ondansetron ODT 4 mg tablet. The contract has an ultimate completion date of April 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc. valued at up to $999,999,999.00, which serves as...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $29,013.80 firm fixed-price delivery order covers the supply of 4,560,376,093 units of the pharmaceutical drug Ondansetron ODT 4 mg Tablet in 30-count packages. The contract has an ultimate completion date of March 27, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,295.76 firm-fixed-price contract is for the delivery of 4,564,128,932 units of the medication Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of April 2, 2024 and was awarded on April 1, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for 4,560,886,465 units of Ondansetron HCL 4 mg tablets. The $20,262.06 firm-fixed-price contract has a completion date of May 11, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the...
- The U.S. government agency the Defense Logistics Agency (DLA) Troop Support Medical has awarded a $11,980.91 firm-fixed-price delivery order (SPE2DX23F2HZY) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,560,975,954 units of 4 mg Ondansetron HCL tablets. The delivery order has a completion date of May 19, 2023 and was awarded on May 18, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,559,720,792 units of Ondansetron ODT 4 mg tablets. The award, valued at $1,225.78, has a firm fixed-price pricing type and an ultimate completion date of January 26, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company,...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB24FA7NUDelivery Order
The federal contract award SPE2DB20D3111|SPE2DB24FA7NU was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,953.32 firm fixed-price delivery order is for the supply of 4,564,478,692 Ondansetron ODT 4 mg tablets, with an ultimate completion date of May 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs globally. The contract award did not have any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 5/2/24 |